hi rastus
604, which recorded the change in the share of the seller, was regularly communicated to the market, as the selling party held a 8.37% pre-sale. however, having been sold a quota equal to 1.87%, I do not believe that there are the obligations to communicate its status with a further 604 as less than 5%. on the contrary, the company will have to register with T20 in the annual report in April, noting that 1.87% is classified as a substantial holder at the 7th / 8th place in the ranking.
the list that will be published in April is the one registered at the end of March, so during these hours. I did not know that the documentation could be requested from the CFO; it would be interesting to know it in advance, even if I believe that at this moment it is particularly sensitive material for the market.
- Forums
- ASX - By Stock
- NEU
- Ann: Disclosure under Listing Rule 4.3D
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.80%
!
$12.54

Ann: Disclosure under Listing Rule 4.3D, page-23
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1215 | $12.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.54 | 804 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 12.480 |
1 | 796 | 12.300 |
1 | 400 | 12.240 |
1 | 3000 | 12.230 |
1 | 761 | 12.210 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 1020 | 1 |
12.710 | 628 | 2 |
12.720 | 1982 | 1 |
12.820 | 3050 | 1 |
12.900 | 5012 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |